Healthcare Industry News: SBRT
News Release - October 29, 2018
cue-Rx(TM) Launch Revolutionizes At-Home Patient Medication DispensingProvides Improved Medication Adherence, Greater Independence for Seniors, and Real-Time Communication to Caregivers
NEW HOPE, Pa., Oct. 29, 2018 -- (Healthcare Sales & Marketing Network) -- Solbright Group, Inc. (OTC: SBRT), soon to be renamed Iota Communications, Inc., recently announced the commercial launch of cue-Rx™, a new medication adherence system that it believes will revolutionize at-home medication dispensing for patients and caregivers by delivering prescriptions in their original containers.
The first medication adherence system that operates with its own dedicated radio communications system, cue-Rx™ attracted attention earlier this month when it was launched at the National Association for Home Care & Hospice Expo in Dallas, TX.
With more than a dozen active trials currently underway, cue-Rx™ begins with an automated device that alerts patients and delivers their prescription at the exact time they should be taking their medication, in their actual prescription container. The cue-Rx™ carousel turns, opens to the correct pill bottle compartment and allows the patient to take their medication as prescribed – right from the original pill bottle. cue-Rx™ provides timely phone, text, and email alerts to clinicians, caregivers, and families in order to quickly identify non-adherent patients. cue-Rx™ is designed for patients at hospitals, in home-care, assisted living facilities, senior living facilities, and continued care retirement communities. The device is also designed for home use – to improve medication adherence long-term, allowing more patients to stay home longer living comfortably and safely.
According to a 2014 NIH study, between $100 and $300 billion of avoidable health care costs have been attributed to nonadherence in the US annually, representing 3% to 10% of total US health care costs.
"As health systems, providers, and families work to better manage high-risk, and high-cost chronic patient populations in order to reduce costs, cue-Rx™ is positioned to play a pivotal role by minimizing non-compliance," said Kevin Casey, President of Solbright/Iota Healthcare. "cue-Rx™ is a plug and play device and connects via its own dedicated radio system directly to the cloud, thus eliminating reliance on either the patient's or the facilities' networks. This flexibility not only offers critical reliability of access to end users, but it also reduces overall costs. Clinicians are enthusiastic about the positive impact cue-Rx™ will have on compliance."
Dr. Daniel Kullukian, M.D. of Surgical Healthcare, LLC in Phoenix, AZ recently reviewed cue-Rx™ for use in a post-acute medication reconciliation trial. "cue-Rx's simple design and powerful software will help our patients stay on track with their medications, improve their quality of life, and give families the peace of mind that their loved ones are taking their meds as prescribed," he said. "When you consider the positive effects of cue-Rx™ across our entire patient population, the savings to our health system from improved compliance will be enormous; largely in our geriatric population."
Solbright/Iota's CEO Barclay Knapp has a positive outlook about the launch of cue-Rx™, citing teamwork and dedication as the pillars that turned the product into a reality. "We've teamed beautifully with our IP partner, One World, as well as our test and trial customers to develop and commercialize cue-Rx™," Knapp said. "We're very excited now to see the product get into the hands of real patients who are benefitting from the device. We are especially pleased that cue-Rx™ is already having a positive impact on the quality of life for those patients in our current trials."
One of those patients, Ms. Erleen Lane, who confirms the value of her cue-Rx™, stated, "I began my cue-Rx™ trail one week ago, immediately following my discharge from the hospital. It has already made improvements in my life. cue-Rx's simple and sleek design, easy-to-use software, and improved alerts will help me stay on track with my medications."
Lane said cue-Rx™ has begun to make her more consistent with her medication dosages and has helped improve her quality of life.
"It is allowing my family the peace of mind that I am taking my medicine as prescribed," she explained. "The best part is, if I forget my meds, cue-Rx™ will call me and my loved ones to remind us. With cue-Rx™, I will not be readmitted to the hospital for medication mismanagement any longer."
The cue-Rx™ product development team continues to add features that are designed to improve the quality of life for patients. The sophisticated onboard microprocessor in cue-Rx™ will allow the product to connect, via Bluetooth or wirelessly, to other wearable and connected peripherals that provide key biometrics for remote, real time monitoring of patients. cue-Rx™ is now actively adding peripheral device partners as well as leading Population Health Portals partners to its hub. This strategy will transform cue-Rx™ from a medication reminder device to a complete and comprehensive hub of wearables and other devices. These wearable devices will feed data in real time via health portals, to providers who can remotely manage these patients.
To learn more about cue-Rx™ and Solbright/Iota, visit https://www.iotacommunications.com/iota-products/healthcare-solutions/cue-rx/.
About Iota Communications, Inc.
Solbright Group, Inc., soon to be renamed Iota Communications, Inc., is operating the first licensed, nationwide wireless network dedicated to the rapidly emerging Machine-to-Machine industry. The company is developing a wide-area, ubiquitous coverage, data radio system based on licensed spectrum and proprietary technology; purpose-built and dedicated solely to M2M applications for the long-term. Iota has locations in Phoenix, Arizona, New Hope, Pennsylvania, and Jacksonville, Florida. To learn more Iota, visit their Website at https://www.iotacommunications.com.
Source: Solbright Group
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.